
Dr Vanessa Tan
PhD(Bristol)
Current positions
Research Fellow
Bristol Medical School (PHS)
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Research interests
I am a Post-doctoral Research Associate in Applied Genetic Epidemiology in the Cancer Research UK (CRUK) programme based in the School of Social and Community Medicine. I am currently working on the design and undertaking of Recall by Genotype (RbG) studies under the supervision of Dr Nicholas Timpson. The RbG studies involve the recruitment of a subset of participants or their biosamples from an existing cohort for more detailed phenotypic analysis. The aim of my research is to understand biological mechanisms underlying cancer risk and progression by undertaking the RbG studies.
I did a cross-disciplinary Ph.D. in Cell Biology and Clinical Epidemiology. My Ph.D. research involved using a unique combination of cell biology and epidemiological approaches to better understand the regulation of fascin-1 in cancer and the translational potential of fascin-1, as well as its regulators, as potential cancer biomarkers.
Projects and supervisions
Research projects
Role of directly measured metabolic profile as an intermediate between adiposity and endometrial cancer: triangulation of evidence from independent sources
Principal Investigator
Role
Co-Principal Investigator
Managing organisational unit
Bristol Medical School (PHS)Dates
01/05/2023 to 01/05/2026
Publications
Recent publications
21/10/2025Adiposity, metabolites and endometrial cancer risk: Inference from combinations of Mendelian randomization and Observational analyses
BMC Cancer
The Effect of Circulating Proteins and Their Role in Mediating Adiposity's Effect on Endometrial Cancer Risk
Cancer Epidemiology Biomarkers and Prevention
Identifying metabolic features of colorectal cancer liability using Mendelian randomization
eLife
Does testosterone mediate the relationship between vitamin D and prostate cancer progression? A systematic review and meta-analysis
Cancer Causes and Control
Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers
PLOS Medicine



